GDTC
Cytomed Therapeutics
$0.90
−$0.09 (−9.09%)Jul 27, 2026
Key metrics
The numbers that frame GDTC today
- Market cap
- $10.65M
- P/E (TTM)
- -3.4
- EV / FCF
- -2.8
- Gross margin
- 100%
- EV / Sales
- 37.0
- ROIC
- -76.2%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.68
- 52wk High
- $3.68
Growth
Revenue and earnings trend for GDTC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GDTC
Is Cytomed Therapeutics a good buy?
No. Cytomed Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. We think Cytomed Therapeutics is selling at a very high price.
What is the market capitalization of GDTC?
Cytomed Therapeutics's market capitalization is $10.65M.
What is the P/E ratio for GDTC stock?
Cytomed Therapeutics's current P/E ratio is -3.4.
What is the 52-week high for GDTC stock?
The 52-week high for Cytomed Therapeutics is $3.68. The current close of $0.90 is 75.5% below that high.
What is the 52-week low for GDTC stock?
The 52-week low for Cytomed Therapeutics is $0.68. The current close of $0.90 is 32.4% above that low.
Does GDTC stock pay dividends?
Cytomed Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for GDTC?
Cytomed Therapeutics's Debt / Equity ratio is 0.07.